| 发明名称 |
Glucagon Antagonists/Inverse Agonists |
| 摘要 |
A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
|
| 申请公布号 |
US2009143592(A1) |
申请公布日期 |
2009.06.04 |
| 申请号 |
US20070949075 |
申请日期 |
2007.12.03 |
| 申请人 |
NOVO NORDISK A/S |
发明人 |
LAU JESPER;MADSEN PETER;SAMS CHRISTIAN;BEHRENS CARSTEN;VAGNER JOSEF;CHRISTENSEN INGE THOGER;LUNDT BEHREND FREDERIK;SIDELMANN ULLA GROVE;THOGERSEN HENNING;LING ANTHONY L.;PLEWE MICHAEL BRUNO;TRUESDALE LARRY KENNETH;JOGENSEN ANKER STEEN;KODRA JANOS TIBOR;SHI SHENGHUA |
| 分类号 |
C07D211/88;C07C57/62;C07C237/36;C07C237/42;C07C243/38;C07C271/56;C07C271/58;C07C275/24;C07C275/26;C07C275/28;C07C275/30;C07C275/34;C07C275/36;C07C275/38;C07C275/42;C07C275/60;C07C275/62;C07C311/47;C07C317/22;C07C317/32;C07C317/42;C07C323/21;C07C323/44;C07D209/08;C07D209/48;C07D211/58;C07D213/75;C07D215/38;C07D231/40;C07D235/30;C07D257/06;C07D277/72;C07D295/13;C07D295/135;C07D307/68;C07D317/66;C07D319/18;C07D319/20;C07D333/20;C07D333/24;C07D333/38;C07D333/60;C07D333/68;C07D333/70;C07D409/12;C07D417/12;C07D487/04 |
主分类号 |
C07D211/88 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
